Drugmaker Merck acquires Prometheus for nearly US$11 billion
Pharmaceutical giant Merck’s acquisition of biotech firm Prometheus Biosciences will accelerate the former’s growing presence in immunology where there remains substantial unmet patient need. – EPA pic, April 17, 2023.
PHARMACEUTICAL giant Merck announced yesterday the purchase of California-based biotech company Prometheus Biosciences for nearly US$11 billion . The two companies “have entered into a definitive agreement under which Merck, through a subsidiary, has agreed to acquire Prometheus for US$200.00 per share in cash for a total equity value of approximately US$10.8 billion,” Merck said in a statement.
Effective July 2018, access to full reports will only be available with a subscription. Sign-up now and enjoy one week free access!
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
DigitalBridge to invest more than RM4 billion in Malaysia, says PM | The Malaysian InsightAnwar says committed to ensuring clean, conducive ecosystem to facilitate investments.
Read more »
US should stop encouraging war in Ukraine, says Lula | The Malaysian InsightBrazilian president urges Washington to ‘start talking about peace’.
Read more »
Montana lawmakers vote to ban TikTok in US state | The Malaysian InsightLegal analysts, critics say bill overreaches, leaving it largely symbolic
Read more »
US police kill man after responding to wrong address, video shows | The Malaysian InsightOfficers get call on domestic violence from 5308 Valley View Ave, go to 5305 instead.
Read more »
US envoy calls for global plan to fight fentanyl scourge | The Malaysian InsightSynthetic opioid can be 50 times more powerful than heroin.
Read more »
Global stocks mixed after weak US retail sales data | The Malaysian InsightDowncast reading countered by surprisingly good earnings from large banks.
Read more »